Issue: October 2015
October 07, 2015
1 min read
Save

Trial Scorecard: PATHWAY-2

Issue: October 2015
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Study of the optimal treatment for patients with resistant hypertension already taking three guideline-directed medical therapies.

Trial Scorecard: PATHWAY-2